EUVIMEDEUVIMED entdecken
Crossref

Zero‐Contrast Percutaneous Left Atrial Appendage Closure: A Large‐Scale, Single‐Center, Real‐World Study

Ahmet Hakan Ateş iD, Mert Doğan iD, Ahmet Kıvrak iD, Cem Çöteli iD, Uğur Nadir Karakulak iD, Uğur Canpolat iD, Necla Özer iD, Hikmet Yorgun iD, Mehmet Levent Sahiner iD, Ergun Baris Kaya iD, Kudret Aytemir iD

Pacing and Clinical Electrophysiology · 2026

DOI: 10.1111/pace.70134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2026. Verfasst von Ahmet Hakan Ateş und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Atrial Appendage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Left atrial appendage closure (LAAC) is a proven stroke prevention method for patients with non‐valvular atrial fibrillation (AF) who are not suitable for long‐term anticoagulation. However, the use of iodinated contrast agents during the procedure can increase the risk of acute kidney injury (AKI), especially in patients with chronic kidney disease (CKD). This study evaluates the safety and effectiveness of a zero‐contrast LAAC technique using transesophageal echocardiography (TEE) and fluoroscopy.

Methods

In this retrospective study, 324 consecutive patients underwent zero‐contrast LAAC between January 2014 and January 2025. All procedures were performed using TEE and fluoroscopy guidance without iodinated contrast agents. The primary safety endpoint was the composite of procedure‐related major complications occurring within 7 days after the procedure. Secondary endpoints included the rate of procedural success.

Results

The mean age was 74.1 ± 9.3 years. CKD was present in 25.6% of the population, including four patients (1.2%) with prior renal transplantation and 19 patients (5.9%) receiving maintenance hemodialysis. The median CHA 2 DS 2 ‐VASc and HAS‐BLED scores were both 4.0. Primary endpoints were observed in 8 (2.46%) patients (all‐cause mortality in 4 patients, device embolization in 2 patients, and major bleeding in 2 patients). The procedural success rate was 99.7%. Vascular access site complications were observed in 5 (1.5%) patients. Renal function assessment showed baseline serum creatinine levels of 1.24 ± 1.30 mg/dL and 1.26 ± 1.32 mg/dL at 24–48 h ( p = 0.847). No cases of acute kidney injury (KDIGO criteria) occurred during the index hospitalization, and renal function remained stable in 83 patients (25.6%) with pre‐existing CKD. Survival analysis stratified by CKD stages demonstrated significantly higher mortality rates with progressive renal dysfunction ( p < 0.001).

Conclusions

Zero‐contrast LAAC guided by TEE and fluoroscopy is a safe and effective alternative to contrast‐enhanced LAAC, with particular advantages in patients with renal dysfunction. These findings support broader adoption of contrast‐avoidance strategies in high‐risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Left Atrial Appendage ClosureAtrial FibrillationAtrial AppendageHumansFemaleMaleRetrospective StudiesAgedEchocardiography, TransesophagealContrast MediaFluoroscopyTreatment OutcomeAged, 80 and overRenal Insufficiency, ChronicStroke

Stichwörter der Autor:innen

LAACTEE guidanceatrial fibrillationcontrast‐induced nephropathyzero‐contrast

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

ORCID-Profile: Ahmet Hakan Ateş, Mert Doğan, Ahmet Kıvrak, Cem Çöteli, Uğur Nadir Karakulak, Uğur Canpolat, Necla Özer, Hikmet Yorgun, Mehmet Levent Sahiner, Ergun Baris Kaya, Kudret Aytemir

Zitieren

APA

Ateş, A. H., Doğan, M., Kıvrak, A., Çöteli, C., Karakulak, U. N., Canpolat, U., Özer, N., Yorgun, H., Sahiner, M. L., Kaya, E. B., & Aytemir, K. (2026). Zero‐Contrast Percutaneous Left Atrial Appendage Closure: A Large‐Scale, Single‐Center, Real‐World Study. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70134

Vancouver

Ateş AH, Doğan M, Kıvrak A, Çöteli C, Karakulak UN, Canpolat U, et al. Zero‐Contrast Percutaneous Left Atrial Appendage Closure: A Large‐Scale, Single‐Center, Real‐World Study. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70134

BibTeX
@article{Ate2026,
  author = {Ateş, Ahmet Hakan and Doğan, Mert and Kıvrak, Ahmet and Çöteli, Cem and Karakulak, Uğur Nadir and Canpolat, Uğur and Özer, Necla and Yorgun, Hikmet and Sahiner, Mehmet Levent and Kaya, Ergun Baris and Aytemir, Kudret},
  title = {Zero‐Contrast Percutaneous Left Atrial Appendage Closure: A Large‐Scale, Single‐Center, Real‐World Study},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70134}
}
Kostenlos starten →